Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — August 2024

Genmab — August 2024

Planlagt Fastgjort Låst Flyttet Genmab
944 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #15

    Black Friday

    1 Reply Last reply
    0
    • B Offline
      B Offline
      bikube
      wrote on sidst redigeret af
      #16

      Flot med et nyt kursmål, der tangerer den gamle ATH på 3320.

      1 Reply Last reply
      0
      • StockBullS Offline
        StockBullS Offline
        StockBull
        wrote on sidst redigeret af
        #17

        Fedt

        1 Reply Last reply
        0
        • nohopeN Offline
          nohopeN Offline
          nohope
          wrote on sidst redigeret af
          #18

          God morgen ? Er det fordi børsen har lukket at det er en god morgen ?

          1 Reply Last reply
          0
          • P Offline
            P Offline
            peter12
            wrote on sidst redigeret af
            #19

            Zacks er positive https://finance.yahoo.com/news/wall-street-analysts-think-genmab-135506419.html

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bibob
              wrote on sidst redigeret af
              #20

              Nohope. Regnede det ved dig i morges.

              1 Reply Last reply
              0
              • P Offline
                P Offline
                peter12
                wrote on sidst redigeret af
                #21

                Interessant artikel om CD38 og udmattede T-celler https://www.lumc.nl/en/news/2024/new-solution-found-for-cmv-and-potentially-other-chronic-viruses-and-cancer/

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #22

                  @Peter12 det var netop den effekt ved dara, der fik os til at tro, at der var en mulighed i solide. Men dara fejlede og kursen fik mega tæsk. Det er muligt, at anti-CD38 behandling har mange muligheder,
                  men måske ikke i fremskreden cancer. Tak for linket !

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    peter12
                    wrote on sidst redigeret af
                    #23

                    Jeg er ikke sikker på det er helt den samme mekanisme. Det nye er at man kan genoplive udmattede T-celler. Den gamle er vist denne beskrivelse https://www.mdanderson.org/publications/cancer-frontline/immunotherapy-fires-up-protein-on-tumors-that-supresses-immune-a.h00-159226512.html

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #24

                      Måske men Genmab/JNJ havde ikke held med dara i solide cancer. Men måske en ide til Genmab, hvis JNJ ikke opt.in. på hexabody CD38.

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #25

                        Aktier: Fra stejl optur til panik https://proinvestor.com/boards/121648

                        1 Reply Last reply
                        0
                        • royalR Offline
                          royalR Offline
                          royal
                          wrote on sidst redigeret af
                          #26

                          Tegner til en "Duck and cover" dag.

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JKY_VH
                            wrote on sidst redigeret af
                            #27

                            Nordea om Genmab "Our Hold rating is unchanged, with a slightly higher DCF-derived fair value of DKK 2,298 (2,259)"

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              Bella1
                              wrote on sidst redigeret af
                              #28

                              Jeg køber!:-)

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                Bella1
                                wrote on sidst redigeret af
                                #29
                                • også Novo!
                                1 Reply Last reply
                                0
                                • concilladoC Offline
                                  concilladoC Offline
                                  concillado
                                  wrote on sidst redigeret af
                                  #30

                                  Panik på det hysteriske marked = gode opkøbsmuligheder i den næste tid 😉

                                  1 Reply Last reply
                                  0
                                  • concilladoC Offline
                                    concilladoC Offline
                                    concillado
                                    wrote on sidst redigeret af
                                    #31

                                    Hvis tiden er med dig (hvilket den altid bør være ved investeringer generelt), så husk Warren Buffet's motto.

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #32

                                      Carnegie höjer riktkursen för Genmab till 2 760 danska kronor (2 720), upprepar köp - BN (Finwire)
                                      2024-08-05 08:16 https://www.placera.se/placera/telegram/2024/08/05/genmab-carnegie-hojer-riktkursen-for-genmab-till-2-760-danska-kronor-2-720-upprepar-kop-bn.html

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #33

                                        Genmab Takes Full Control of Acasunlimab Development Program https://www.globenewswire.com/news-release/2024/08/05/2924128/0/en/Genmab-Takes-Full-Control-of-Acasunlimab-Development-Program.html

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #34

                                          BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update https://www.globenewswire.com/news-release/2024/08/05/2924129/0/en/BioNTech-Announces-Second-Quarter-2024-Financial-Results-and-Corporate-Update.html -mentioning Acasunlimab at ESMO

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper